Industry News
Pharmaceutical Industry News
¿Un medicamento para que tu perro viva más?
Los fármacos para la longevidad de nuestros compañeros caninos están cada vez más cerca de hacerse realidad. También plantean interrogantes.
Congress Must Act to Eliminate Hepatitis C
Congress has a chance to eliminate hepatitis C in the United States.
Israel-Hamas Truce Appears to Enter Another Day, and More
Plus, how money is flowing out of China and scientists are one step closer to a drug extending the lives of dogs.
Could Longevity Drugs for Dogs Extend Your Pet’s Life?
Longevity drugs for our canine companions are moving closer to reality. They also raise questions about what it might mean to succeed.
This Quiet Blockbuster at the Supreme Court Could Impact All Americans
This term largely revolves around a single question: Will our government retain the capacity to address the most pressing issues of our time?
Thanksgiving Is All About Food. Will Ozempic Make It Better or Worse?
The weight-loss drugs that have swept into the cultural conversation crash into a holiday that’s all about food.
Sickle-Cell Treatment Created With Gene Editing Wins U.K. Approval
The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient.
Cannabis for Seniors: Why Older Adults Are Opting for Medical Marijuana
Older people are using cannabis more than ever. Here’s what to know about its potential medicinal benefits and side effects as we age.
Amazon to Stop Selling Seven Eyedrops After F.D.A. Warning
The Food and Drug Administration told the online retailer in a letter this week that the products were not approved for sale in the United States.
Zepbound, el nuevo medicamento aprobado por la FDA para perder peso
Este fármaco tiene el mismo compuesto que Mounjaro, el muy solicitado medicamento para la diabetes. Su aprobación por parte de la FDA podría abrir el camino para su cobertura en los seguros médicos.
Weight Loss Drug Wegovy Can Cut Heart Attack Risk for Some, Study Shows
The results of a large clinical trial suggest the obesity medication could also change the landscape of cardiovascular care.
Gonorrhea Is Becoming Drug Resistant. Scientists Just Found a Solution.
A new antibiotic, zoliflodacin, is as effective as the current standard of care. Its creation may hasten the arrival of other needed antibiotics.
‘Crisis vergonzosa’: la sífilis congénita repunta en EE. UU.
La sífilis congénita se ha vuelto más de 10 veces más común en la última década, según información de los CDC.
The Republican Alternatives to Trump
Responses to an essay offering advice on winning the nomination. Also: Civil debates; questions for Hamas and Israel; fraught times; antipsychotic drugs.
Sexual Dysfunction After Stopping SSRI Antidepressants
Some patients are speaking up about lasting sexual problems after stopping antidepressants, a poorly understood condition.
The Traffic Jam in Low Earth Orbit
Elon Musk's satellites. Stuffed animals. Tomatoes? You wouldn't believe what's circling Earth these days.
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy
Zepbound, which is already sold by Eli Lilly as the diabetes treatment Mounjaro, was shown to reduce patients’ weight by as much as one-fifth in drug trials.
FDA Approves Zepbound, A Drug Like Ozempic, for Weight Loss. Here’s What to Know.
The obesity medication contains tirzepatide, the same active ingredient in the diabetes drug Mounjaro.
Infants Are Born With Syphilis in Growing Numbers, a Sign of a Wider Epidemic
Congenital syphilis has become more than ten times as common over the past decade, the C.D.C. reported. “The situation is dire,” said one expert.
Charity Watch Auction Stalled by Social Media Outcry
A social media outcry over its more than $100 million in donations led Only Watch, one of the industry’s most high-profile events, to cancel its Nov. 5 sale.